Freedom Day Solutions’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.13M | Sell |
9,806
-738
| -7% | -$164K | 0.57% | 57 |
|
|
2025
Q4 | $2.41M | Sell |
10,544
-139
| -1% | -$31.7K | 0.65% | 52 |
|
|
2025
Q3 | $2.47M | Sell |
10,683
-36
| -0.3% | -$7.33K | 0.67% | 53 |
|
|
2025
Q2 | $1.99M | Sell |
10,719
-360
| -3% | -$66.9K | 0.59% | 60 |
|
|
2025
Q1 | $2.32M | Sell |
11,079
-539
| -5% | -$105K | 0.71% | 45 |
|
|
2024
Q4 | $2.06M | Sell |
11,618
-375
| -3% | -$68.9K | 0.62% | 52 |
|
|
2024
Q3 | $2.37M | Sell |
11,993
-168
| -1% | -$31.4K | 0.74% | 43 |
|
|
2024
Q2 | $2.09M | Sell |
12,161
-588
| -5% | -$97.4K | 0.71% | 47 |
|
|
2024
Q1 | $2.32M | Sell |
12,749
-517
| -4% | -$89.1K | 0.82% | 37 |
|
|
2023
Q4 | $2.06M | Sell |
13,266
-311
| -2% | -$45.3K | 0.81% | 41 |
|
|
2023
Q3 | $2.02M | Sell |
13,577
-616
| -4% | -$90.4K | 0.89% | 35 |
|
|
2023
Q2 | $1.91M | Sell |
14,193
-1,628
| -10% | -$239K | 0.85% | 37 |
|
|
2023
Q1 | $2.5M | Sell |
15,821
-729
| -4% | -$111K | 1.18% | 16 |
|
|
2022
Q4 | $2.67M | Sell |
16,550
-744
| -4% | -$114K | 1.33% | 9 |
|
|
2022
Q3 | $2.32M | Sell |
17,294
-652
| -4% | -$93.6K | 1.26% | 17 |
|
|
2022
Q2 | $2.75M | Sell |
17,946
-663
| -4% | -$101K | 1.38% | 11 |
|
|
2022
Q1 | $3.02M | Sell |
18,609
-526
| -3% | -$76.4K | 1.29% | 16 |
|
|
2021
Q4 | $2.59M | Sell |
19,135
-231
| -1% | -$27.3K | 1.04% | 38 |
|
|
2021
Q3 | $2.09M | Sell |
19,366
-981
| -5% | -$112K | 0.98% | 45 |
|
|
2021
Q2 | $2.29M | Sell |
20,347
-1,293
| -6% | -$146K | 1.09% | 44 |
|
|
2021
Q1 | $2.34M | Buy |
21,640
+423
| +2% | +$45.2K | 1.24% | 38 |
|
|
2020
Q4 | $2.27M | Buy |
21,217
+1,881
| +10% | +$181K | 1.24% | 37 |
|
|
2020
Q3 | $1.69M | Buy |
19,336
+1,540
| +9% | +$145K | 1% | 50 |
|
|
2020
Q2 | $1.75M | Buy |
17,796
+3,649
| +26% | +$321K | 1.16% | 42 |
|
|
2020
Q1 | $1.08M | Buy |
14,147
+5,708
| +68% | +$486K | 0.92% | 54 |
|
|
2019
Q4 | $747K | Buy |
8,439
+3,026
| +56% | +$251K | 0.5% | 66 |
|
|
2019
Q3 | $410K | Sell |
5,413
-2,053
| -27% | -$141K | 0.3% | 72 |
|
|
2019
Q2 | $543K | Sell |
7,466
-1,040
| -12% | -$81.7K | 0.41% | 69 |
|
|
2019
Q1 | $685K | Sell |
8,506
-975
| -10% | -$79.8K | 0.56% | 66 |
|
|
2018
Q4 | $874K | Sell |
9,481
-1,581
| -14% | -$139K | 0.92% | 49 |
|
|
2018
Q3 | $1.05M | Sell |
11,062
-12,858
| -54% | -$1.22M | 0.83% | 52 |
|
|
2018
Q2 | $2.22M | Buy |
23,920
+463
| +2% | +$45.2K | 1.81% | 16 |
|
|
2018
Q1 | $2.22M | Buy |
23,457
+12,651
| +117% | +$1.39M | 1.94% | 15 |
|
|
2017
Q4 | $1.04M | Buy |
+10,806
| New | +$1.02M | 0.88% | 49 |
|
Other funds holding ABBV
VCM
VPM
Freedom Day Solutions's ABBV Position: Q1 2026 in Review
Freedom Day Solutions reduced its AbbVie (ABBV) stake by 7% in Q1 2026, selling an estimated $164K and leaving 9,806 shares worth $2.13M. The position accounts for 0.57% of the portfolio, ranked #57.
Freedom Day Solutions first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.02M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Freedom Day Solutions held 9,806 shares of AbbVie worth $2.13M as of Q1 2026.
- Freedom Day Solutions sold 738 AbbVie shares in Q1 2026, an estimated $164K.
- AbbVie made up 0.57% of Freedom Day Solutions's portfolio in Q1 2026, its #57 holding.
- Freedom Day Solutions first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- Freedom Day Solutions's AbbVie position peaked at $3.02M in Q1 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Freedom Day Solutions's 13F filing for Q1 2026, filed 5 May 2026.